surface antigen detection with non-fluorescent, antibody-coated microbeads: an alternative method compatible with conventional fluorochrome-based labeling.

NLM AIDSLINE Surface antigen detection with non-fluorescent, antibody-coated microbeads: an alternative method compatible with conventional fluorochrome-based labeling. Fortin M; Hugo P; PROCREA BioSciences Inc., Ville Mont-Royal, Quebec,
September 30, 1999

Cytometry. 1999 May 1;36(1):27-35. Unique Identifier : AIDSLINE BACKGROUND: Our goal was to devise a new labeling technique allowing the flow cytometric detection of an additional cell surface marker without the need for a supplementary fluorochrome. METHODS: Non-fluorescent polystyrene latex microbeads (0.1 or 0.5 microm in diameter) were coated with monoclonal antibodies (mAbs) by adsorption. Upon binding to their specific antigen on the surface of the cell, mAb-coated beads induced a dramatic shift in the side scatter channel (SSC), resulting in a well-defined cell population. RESULTS: We show that expression of CD4 on murine peripheral lymphocytes, labeled with anti-CD4 mAb-coated beads, can be readily detected through an amplification of the SSC signal. Simultaneous labeling of lymphocytes with phycoerythrin- (PE)-conjugated anti-CD4 mAb and anti-CD4 mAb-coated beads, showed that all PE+ cells were SSChigh, thus establishing the specificity of the technique. Hence, we have demonstrated that staining with mAb-coated beads could be combined to conventional labeling methods with fluorochrome-conjugated mAbs. Using a standard 488 nm single laser cytometer, we have performed a five-parameter analysis, simultaneously detecting fluorescein isothiocyanate (FITC), PE, RED670 and RED613, in combination with SSC signal modulation induced by mAb-coated beads. Moreover, we have shown that beads coated with mAbs directed against various antigens (CD45R, Mac-1, and TCRbeta) can be used on various tissues, namely lymph nodes, spleen, or bone marrow. CONCLUSIONS: mAb-coated latex beads can therefore easily be used as an additional surface label, and provide a simple and reliable mean to upgrade the analysis capabilities of standard flow cytometry units. JOURNAL ARTICLE Antibodies, Monoclonal/IMMUNOLOGY/PHARMACOLOGY Antibody Specificity Antigens, CD4/ANALYSIS/IMMUNOLOGY Antigens, CD45/ANALYSIS/IMMUNOLOGY Antigens, CD8/ANALYSIS/IMMUNOLOGY Antigens, Differentiation/ANALYSIS/IMMUNOLOGY Antigens, Surface/ANALYSIS/IMMUNOLOGY CD4-Positive T-Lymphocytes/CHEMISTRY/CYTOLOGY/IMMUNOLOGY CD8-Positive T-Lymphocytes/CHEMISTRY/CYTOLOGY/IMMUNOLOGY Flow Cytometry/METHODS/STANDARDS Fluorescent Dyes Human *Microspheres NAD+ Nucleosidase/ANALYSIS/IMMUNOLOGY Receptors, Antigen, T-Cell, alpha-beta/ANALYSIS/IMMUNOLOGY Reproducibility of Results Staining/METHODS Support, Non-U.S. Gov't

Most Read: Latest Added Related Topics White House LGBT Conference on HIV/AIDS UNITED STATES: White House in Atlanta: LGBT AIDS Conference No more single-theme conferences: global HIV prevention conference planned FHI 360 Senior Scientist Lut Van Damme Receives International Microbicide Conference Lifetime Achievement Award Equatorial Guinea Ministry of Health and Social Welfare and UNICEF Refute Erroneous AIDS Prevalence Figures Photographs from A Day with HIV Now Online Bulgaria urges Libya to investigate AIDS nurses case Engineers enter fight against AIDS in Africa Gilead’s Complera® Non-Inferior to Atripla® Among Treatment-Naive HIV Patients UN chief Ban calls world leaders to end Aids by 2020 CANADA: Celibate Homosexual Men Now Allowed to Donate Blood in Canada AFRICA: UN: AIDS Deaths Down, Treatment Up in Africa MICHIGAN: STD Fee for Jackson County Walk-In Clinic Takes Effect June 3 NEW YORK: Catskill Hospital Warns That Insulin Pens May Have Been Reused DELAWARE: Cape Henlopen Theatre Academy to Host 'Magic to Do' May 25 GLOBAL: HIV Outcomes Could Improve by Integrating Treatment of Comorbid Mental Illness CANADA: Stop Paid Blood Donor Clinics in Toronto, Victims Say UNITED STATES: How Sexual Stigma Is Undermining HIV Treatment on American Indian Reservations HHS Office for Civil Rights launches campaign to increase awareness of HIPAA rights among HIV-positive Black men Blue Cross To Allow HIV/AIDS Patients to "Opt-Out" of Mandatory Mail-Order Rx Drug Program, Announces Consumer Watchdog CANADA: Fast, Cheap Methods of Diagnosing Infectious Disease? They're Coming Sooner Than You Think NIH Scientists Create New Tool for Identifying Powerful HIV Antibodies: Advance Could Speed HIV Vaccine Research KOREA: U.S. Non-Profit Group to Build Tuberculosis Center in Pyongyang Feuding antibodies blocked HIV vaccine Sustiva (efavirenz) pediatric patients labeling update Prezista (darunavir) labeling changes Climbing against gender-based violence: A quest for dignity, equality and justice Boehringer Ingelheim's Faldaprevir-Based Treatment Regimen Achieved Viral Cure in up to 80 Percent of Patients with Hepatitis C in Phase 3 Pivotal Trial Changes to label for Atripla (efavirenz/emtricitabine/tenofovir disoproxil fumarate) tablets Antibody evolution could guide HIV vaccine development
Information in this article was accurate in September 30, 1999. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.